Skip to main content

Advertisement

Log in

Should patients treated with oral anti-coagulants be operated on within 48 h of hip fracture?

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

To investigate if patients treated with oral anticoagulants (OAC) have delayed surgical intervention (more than 48 h) compared to patients without OAC therapy, and if there is an impact to surgery timing on hospitalization length and mortality. A retrospective cohort study of all patients aged over 65 registered with a new diagnosis of hip fracture who underwent surgery in one of the general hospitals run by Clalit, Israel between 01/01/2014 and 31/12/2017. Data was retrieved for patient demographics, OAC treatment, and Charlson comorbidity index. 5828 patients were operated for hip fractures, mean age was 82.8 years (65–108), 4013 (68.8%) were female. 415 were treated with direct oral anticoagulants (DOACs) (7.1%) and 311 with warfarin (5.3%) prior to their hospitalization. Patients taking OAC were less likely to be operated within 48 h from arrival to the hospital compared to patients not receiving OAC. The 30 day mortality was 4.2% among patients not receiving OAC, 6.0% among patients taking DOACs and 10.0% among patients receiving warfarin (p < 0.001). Adjusted odds ratio for mortality at 30 day among patients taking DOACs was similar to patients who didn't take OAC. (OR 1.0, CI 0.7, 1.6). The 30 day mortality rate of patients who were receiving OAC (either DOACs or warfarin) was not significantly different whether patients were operated within 48 h or not. Mortality rate was highest among patients taking warfarin. For patients who received DOACs, operation within 48 h wasn't associated with lower mortality rate. In these patients it seemed reasonable to adjust surgery time according to patients' characteristics and needs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. No authors listed (2017) Hip fracture: management. https://www.nice.org.uk/guidance/cg124. Accessed 16 May 2020.

  2. Kanis JA, Odén A, McCloskey EV, Johansson H, Wahl DA, Cooper C, IOF Working Group on Epidemiology and Quality of Life (2012) A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int 23(09):2239–2256

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Lewiecki EM, Wright NC, Curtis JR et al (2017) Hip fracture trends in the United States, 2002 to 2015. Osteoporos Int 22:465

    Google Scholar 

  4. Braithwaite RS, Col NF, Wong JB (2003) Estimating hip fracture morbidity, mortality and costs. J Am Geriatr Soc 51:364–370. https://doi.org/10.1046/j.1532-5415.2003.51110.x

    Article  PubMed  Google Scholar 

  5. Leal J, Gray AM, Prieto-Alhambra D et al (2016) Impact of hip fracture on hospital care costs: a population-based study. Osteoporos Int 27:549–558

    Article  CAS  PubMed  Google Scholar 

  6. Papadimitriou N, Tsilidis KK, Orfanos P et al (2017) Burden of hip fracture in disability adjusted life-years: a pooled analysis of prospective cohorts in the CHANCES consortium. Lancet Public Health. https://doi.org/10.1016/S2468-2667(17)30046-4

    Article  PubMed  Google Scholar 

  7. Griffin XL, Parsons N, Achten J, Fernandez M, Costa ML (2015) Recovery of health related quality of life in a United Kingdom hip fracture population. The Warwick Hip Trauma Evaluation—a prospective cohort study. Bone Joint J. 97B(3):372–382. https://doi.org/10.1302/0301-620X.97B3.35738

    Article  Google Scholar 

  8. White SM, Griffiths R (2011) Projected incidence of proximal femoral fracture in England: a report from the NHS hip fracture anaesthesia network (HIPFAN). Injury 42(11):1230–1233. https://doi.org/10.1016/j.injury.2010.11.010

    Article  CAS  PubMed  Google Scholar 

  9. Roche JJ, Wenn RT, Sahota O, Moran CG (2005) Effect of comorbidities and postoperative complications on mortality after hip fracture in elderly people: prospective observational cohort study. BMJ 331:1374

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Abrahamsen B, van Staa T, Ariely R, Olson M, Cooper C (2009) Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int 20:1633–1650

    Article  CAS  PubMed  Google Scholar 

  11. Orosz GM, Magaziner J, Hannan EL et al (2004) Association of timing of surgery for hip fracture and patient outcomes. JAMA 291:1738–1743

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Shiga T, Wajima Z, Ohe Y (2008) Is operative delay associated with increased mortality of hip fracture patients? Systematic review, meta-analysis, and meta-regression. Can J Anesth 55:146–154

    Article  PubMed  Google Scholar 

  13. Moja L, Piatti A, Pecoraro V et al (2012) Timing matters in hip fracture surgery: patients operated within 48 hours have better outcomes. A meta-analysis and meta-regression of over 190,000 patients. PLoS ONE 7(10):46175. https://doi.org/10.1371/journal.pone.0046175

    Article  CAS  Google Scholar 

  14. Simunovic N, Devereaux PJ, Sprague S et al (2010) Effect of early surgery after hip fracture on mortality and complications: systematic review and meta-analysis. CMAJ 182(15):1609–1616. https://doi.org/10.1503/cmaj.092220

    Article  PubMed  PubMed Central  Google Scholar 

  15. Khan SK, Kalra S, Khanna A, Thiruvengada MM, Parker MJ (2009) Timing of surgery for hip fractures: a systematic review of 52 published studies involving 291,413 patients. Injury 40(7):692–697

    Article  PubMed  Google Scholar 

  16. https://www.clinicalguidelines.gov.au/portal/2393/australian-and-new-zealand-guideline-hip-fracture-care-improving-outcomes-hip-fracture. Accessed 16 May 2020.

  17. The National Program for Quality Indicators (2019) For general and geriatric hospitals, psychiatric hospitals, mother & baby health centers and emergency medical services annual report for 2013–2018 quality and safety. Division Health Services Research, Department Israel Ministry of Health, Jerusalem

    Google Scholar 

  18. Forni S, Pieralli F, Sergi A, Lorini C, Bonaccorsi G, Vannucci A (2016) Mortality after hip fracture in the elderly: the role of a multidisciplinary approach and time to surgery in a retrospective observational study on 23,973 patients. Arch Gerontol Geriatr 66:13–17

    Article  PubMed  Google Scholar 

  19. Walid S, Anat A, Zomoroda A-F, Shai C, Gad R, Meir P (2020) Preoperative direct oral anticoagulants treatment and all-cause mortality in elderly patients with hip fracture: a retrospective cohort study. Thromb Res 189:48–54. https://doi.org/10.1016/j.thromres.2020.03.002

    Article  CAS  Google Scholar 

  20. Tal FR, Steven V, Maria V, Avi L, Yael H, Pia R, Mustafa YG (2018) Spectre morbidity and mortality after fragility hip fracture surgery in patients receiving vitamin K antagonists and direct oral anticoagulants. Thromb Res 166:106–112. https://doi.org/10.1016/j.thromres.2018.04.022

    Article  CAS  Google Scholar 

  21. Devereaux PJ, Mrkobrada M, Sessler DI et al (2014) Aspirin in patients undergoing noncardiac surgery. N Engl J Med 370:1494–1503. https://doi.org/10.1056/NEJMoa1401105

    Article  CAS  PubMed  Google Scholar 

  22. Chechik O, Thein R, Fichman G, Haim A, Ben Tov T, Steinberg EL (2011) The effect of clopidogrel and aspirin on blood loss in hip fracture surgery. Injury 42:1277–1282. https://doi.org/10.1016/j.injury.2011.01.011

    Article  PubMed  Google Scholar 

  23. Loo SY, Dell'Aniello S, Huiart L et al (2017) Trends in the prescription of novel oral anticoagulants in UK primary care. Br J Clin Pharmacol 83:2096–2106

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Pollack CV, Reilly PA, Eikelboom J et al (2015) Idarucizumab for dabigatran reversal. N Engl J Med 373:511–520

    Article  CAS  PubMed  Google Scholar 

  25. Connolly SJ, Crowther M, Eikelboom JW et al (2019) Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors. N Engl J Med. 380(14):1326–1335. https://doi.org/10.1056/NEJMoa1814051

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Grandone E, Ostuni A, Tiscia GL, Barcellona D, Marongiu F (2019) Management of patients taking oral anticoagulants who need urgent surgery for hip fracture. Semin Thromb Hemost 45(02):164–170

    Article  CAS  PubMed  Google Scholar 

  27. Steffel J, Verhamme P, Potpara TS et al (2018) The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary. Europace. 20(8):1231–1242. https://doi.org/10.1093/europace/euy054

    Article  PubMed  Google Scholar 

  28. Bruckbauer M, Prexl O, Voelckel W et al (2019) Impact of direct oral anticoagulants in patients with hip fractures. J Orthop Trauma 33(1):e8–e13. https://doi.org/10.1097/BOT.0000000000001329

    Article  PubMed  Google Scholar 

  29. National Clinical Guideline Centre (2011) The management of hip fracture in adults NICE clinical guidelines, no. 124. Royal College of Physicians, London

    Google Scholar 

  30. Pincus D, Ravi B, Wasserstein D et al (2017) Association between wait time and 30-day mortality in adults undergoing hip fracture surgery. JAMA 318(20):1994–2003. https://doi.org/10.1001/jama.2017.17606

    Article  PubMed  PubMed Central  Google Scholar 

  31. Barry M, Harold A, David S, Tim C (2018) Should surgery be delayed in patients taking direct oral anticoagulants who suffer a hip fracture? A retrospective, case-controlled observational study at a UK major trauma centre. BMJ Open 8(4):e020625. https://doi.org/10.1136/bmjopen-2017-020625

    Article  Google Scholar 

  32. Chan YH, Lee HF, Chao TF et al (2019) Real-world comparisons of direct oral anticoagulants for stroke prevention in Asian patients with non-valvular atrial fibrillation: a systematic review and meta-analysis. Cardiovasc Drugs Ther. https://doi.org/10.1007/s10557-019-06910-z

    Article  PubMed  Google Scholar 

  33. Liew A, O'Donnell M, Douketis J (2014) Comparing mortality in patients with atrial fibrillation who are receiving a direct-acting oral anticoagulant or warfarin: a meta-analysis of randomized trials. J Thromb Haemost 12(9):1419–1424. https://doi.org/10.1111/jth.12651

    Article  CAS  PubMed  Google Scholar 

  34. Schuetze K, Eickhoff A, Dehner C, Gebhard F, Richter PH (2019) Impact of oral anticoagulation on proximal femur fractures treated within 24 h—a retrospective chart review. Injury 50(11):2040–2044. https://doi.org/10.1016/j.injury.2019.09.011

    Article  CAS  PubMed  Google Scholar 

  35. Hoerlyck C, Ong T, Gregersen M, Damsgaard EM et al (2020) anticoagulants affect outcomes of hip fracture surgery? A cross-sectional analysis. Arch Orthop Trauma Surg 140(2):171–176. https://doi.org/10.1007/s00402-019-03240-5

    Article  PubMed  Google Scholar 

  36. Heeringa J, van der Kuip DA, Hofman A et al (2006) Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 27(8):949

    Article  PubMed  Google Scholar 

  37. Fabrizio L, Tiziana C, Stefano D (2014) Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol 6:213–220

    Google Scholar 

Download references

Funding

None

Author information

Authors and Affiliations

Authors

Contributions

All authors had substantial contributions to the conception and the design of the work and interpretation of data. All authors have approved the submitted version

Corresponding author

Correspondence to Michal Shani.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Ethics approval

The study was approved by the ethics committee of Meir Medical Center, Kfar Saba, Israel.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shani, M., Yahalom, R., Comaneshter, D. et al. Should patients treated with oral anti-coagulants be operated on within 48 h of hip fracture?. J Thromb Thrombolysis 51, 1132–1137 (2021). https://doi.org/10.1007/s11239-020-02261-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-020-02261-x

Keywords

Navigation